Product Images Fosinopril Sodium

This is a table showing the incidence of clinical adverse events in patients with hypertension who were in placebo-controlled trials for Fosinopril Sodium. The table compares the incidence and discontinuation rates of the adverse events in patients taking Fosinopril Sodium versus patients taking a placebo. The adverse events listed are cough, dizziness, and nausea/vomiting.*

This is a list of clinical adverse events documented in placebo-controlled trials related to heart failure for a medication called Fosinopril Sodium. These events include dizziness, cough, hypotension, musculoskeletal pain, nausea/vomiting, diarrhea, chest pain (non-cardiac), upper respiratory infection, orthostatic hypotension, subjective cardiac rhythm disturbances, and weakness. The table shows the incidence of these events and the rate of discontinuation for Fosinopril Sodium compared to placebo.*

Each tablet contains 10mg of Estesfene, a medication used to treat high blood pressure. It is only available with a prescription and should be stored at room temperature, protected from moisture. The usual dosage should be determined by consulting the package insert. The tablets come in a child-resistant container and should be kept out of reach of children. This medication is manufactured by InvaGen Pharmaceuticals, a subsidiary of Cipla Ltd, and is distributed by Cipla USA, Inc. The lot number, manufacturing date, and expiration date are also provided.*

This is a description of a prescription drug called "Blemirtcs" with the active ingredient "OSINOPril" and a strength of "oo mg". The packaging contains 90 tablets with a child-resistant closure and the National Drug Code (NDC) is 69057-857-05. The dosage information is included in the package insert. The manufacturer is InvaTech Pharmaceuticals Inc. and the drug is distributed by Cipla USA Inc. It is important to keep this medication out of the reach of children.*

This is a description of a medication called Fosinopril Sodium, USP in tablet form. Each tablet contains 40 mg and should be stored at room temperature. The medication should be dispensed in a child-resistant container and kept out of the reach of children. The standard dosage information can be found in the package insert. The medication is manufactured by InvaGen Pharmaceuticals, Inc., a subsidiary of Cipla Ltd., and is distributed via Cipla USA, Inc. in Hauppauge, NY. The description also includes a GTIN and SN number.*